Hirofumi Jono

Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism

Kye‐Im Jeon, Xiangbin Xu, Toru Aizawa et al. · Proceedings of the National Academy of Sciences · 2010 · 236 citations

Medicine, Medicinal Chemistry, Pharmacology +17

The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7

Hiroki Yoshida, Hirofumi Jono, Hirofumi Kai et al. · Journal of Biological Chemistry · 2005 · 199 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB

Hirofumi Jono, Jae Hyang Lim, Lin Feng Chen et al. · Journal of Biological Chemistry · 2004 · 180 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study

Mitsuharu Ueda, Yoko Horibata, Makoto Shono et al. · Modern Pathology · 2011 · 163 citations · Full text

Medicine, Neurology, Pathology +12

Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and <i>In vivo</i> Growth of Human Oral Squamous Cell Carcinoma

Satoru Shinriki, Hirofumi Jono, Kazutoshi Ota et al. · Clinical Cancer Research · 2009 · 161 citations · Full text

Medicine, Immunology, Oncology +17